ArticleBriefings in bioinformatics2026
A knowledge-guided deep learning framework for quantitative nucleic acid testing.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Nucleic acid testing is widely used in tumor screening, genetic disease detection as well as prenatal diagnosis, and it especially plays a significant and irreplaceable role in detecting and controlling outbreaks or new infectious diseases. Currently, nucleic acid detection instruments measure target concentrations primarily through optical detection techniques. The characterization of the relationship between optical signals and biochemical reactions is a key technology of current nucleic acid detection instruments. Usually, the number of target gene fragments in a sample is very small, and gene amplification by fluorescence quantitative polymerase chain reaction is currently the most widely used detection method for clinical nucleic acid detection instruments. As the sequence and length of target gene fragments, amplification bio-reagent systems, sample types and amplified light detection systems vary, fluorescence value assessment needs to meet individual testing requirements. In addition, large-scale universal screening efforts pose an even greater challenge to the generality of assessment methods when targeting different detection scenarios for the same virus. The fluorescence value-target sequence replication rate relationship model proposed in this paper is both personalized and universal, and can accurately assess the results of nucleic acid testing based on fluorescence values.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.